3xFNLDD/pMXs-puro Citations (3)

Originally described in: Identification of telomere-associated molecules by engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP).
Fujita T, Asano Y, Ohtsuka J, Takada Y, Saito K, Ohki R, Fujii H Sci Rep. 2013 Nov 8;3:3171. doi: 10.1038/srep03171. PubMed Journal

---

Articles Citing 3xFNLDD/pMXs-puro

Articles
Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells. Kozono S, Lin YM, Seo HS, Pinch B, Lian X, Qiu C, Herbert MK, Chen CH, Tan L, Gao ZJ, Massefski W, Doctor ZM, Jackson BP, Chen Y, Dhe-Paganon S, Lu KP, Zhou XZ. Nat Commun. 2018 Aug 9;9(1):3069. doi: 10.1038/s41467-018-05402-2. PubMed
Template Activating Factor-I alpha Regulates Retroviral Silencing during Reprogramming. Bui PL, Nishimura K, Seminario Mondejar G, Kumar A, Aizawa S, Murano K, Nagata K, Hayashi Y, Fukuda A, Onuma Y, Ito Y, Nakanishi M, Hisatake K. Cell Rep. 2019 Nov 12;29(7):1909-1922.e5. doi: 10.1016/j.celrep.2019.10.010. PubMed
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy. Koikawa K, Kibe S, Suizu F, Sekino N, Kim N, Manz TD, Pinch BJ, Akshinthala D, Verma A, Gaglia G, Nezu Y, Ke S, Qiu C, Ohuchida K, Oda Y, Lee TH, Wegiel B, Clohessy JG, London N, Santagata S, Wulf GM, Hidalgo M, Muthuswamy SK, Nakamura M, Gray NS, Zhou XZ, Lu KP. Cell. 2021 Sep 2;184(18):4753-4771.e27. doi: 10.1016/j.cell.2021.07.020. Epub 2021 Aug 12. PubMed

If you have published an article using this material, please email us at to have your article added to this page.